Pancreatic Cancer Market Share

North American Market Forecast

The pancreatic cancer market in the North America is projected to be the largest with a share of about 32% by the end of 2037. The growth of the market can be attributed majorly to the increasing adoption of new technologies for the treatment of cancer cases in the region. In addition, there has been a rise in the number of clinics providing chemotherapy in the countries such as the United States, that is further adding opportunities for the market’s growth in the region.

Asia Pacific Market Statistics

The Asia Pacific region is projected to hold around 28% share of the global pancreatic cancer market by 2037. The increasing number of diagnostic tests occurring in the region with a high prevalence rate is also driving the market growth. The rising pharmaceutical companies across the region with clinical trials to develop new drugs are estimated to hike the market growth in the Asia Pacific region.